It may not be necessary to have a generic-like strategy for the developed markets of US and Western Europe

It may not be necessary to have a generic-like strategy for the developed markets of US and Western Europe

Shiraz Bugwadia and Prashant Jain, Life Sciences and Healthcare Team, o3 Capital Global Advisor Indian pharma sector: Strong growth outlook beyond defensive play
Jay Shankar, Economist – Vice President, Religare Capital Markets It is essential for Indian outsourcing firms to demonstrate value and quality to differentiate their offerings from other countries
Hitesh Sharma, Partner & Leader and Rahul Patni, Senior Manager, Health Sciences Practice, Ernst & Young There will be an increased investor confidence due to the defensive nature of the sector
Vikram Gupta, Chief Operating Officer, IndiaVenture Advisors A multi-faceted growth
Jumana Barnagarwala, Head-Healthcare Consulting, Datamonitor, India 2010 can expect a surge in strategic partnerships with a particular focus on emerging markets
Hitesh Gajaria, Executive Director, KPMG India Recession has brought emerging markets such as India to the forefront of attention
Sudhir Kant, President, Millipore India 2010’s three magic bullets: unite, educate and the need for increased government support
Aasif Khan, Managing Director, Fabtech Technologies